Related Experiment Video
Updated: Jul 20, 2026
11:31
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
[Animal trials for mPEG-modified red blood cells]
Yan Qiu1, Ying-Xia Tan, Li-Li Li
1Beijing Red Cross Blood Center, Beijing 100088, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 25, 2006
Summary
Modified red blood cells (RBCs) showed decreased survival rates in transfusion studies. Mouse RBC transfusion results are not reliable for evaluating modified human RBC longevity and safety.
Area of Science:
- Biomedical Science
- Hematology
- Biotechnology
Background:
- Red blood cells (RBCs) are critical for oxygen transport.
- Modifying RBCs aims to improve their properties for therapeutic applications.
- Assessing the survival and safety of modified RBCs is essential before clinical use.
Purpose of the Study:
- To investigate the 24-hour survival rates of transfused modified and unmodified RBCs.
- To compare survival rates between homogeneous and heterogeneous animal transfusion models.
- To determine the influence of modification methods and animal species on RBC survival.
Main Methods:
- RBCs from mice, monkeys, pigs, and humans were labeled with FITC.
- Modified and unmodified RBCs were transfused into both same-species (homogeneous) and different-species (heterogeneous) recipients.
- Survival rates were assessed at 24 hours post-transfusion.
Main Results:
- Unmodified mouse RBCs had a 74% survival rate in mice, while modified mouse RBCs had a 45% survival rate.
- Unmodified human RBCs had an 8% survival rate in mice, compared to 5% for modified human RBCs (no significant difference).
- Homogeneous transfusion of modified monkey RBCs showed 90% survival, while modified human and pig RBCs had 0% survival in monkeys at 24 hours.
Conclusions:
- RBC labeling methods and mouse species do not affect 24-hour survival rates.
- mPEG type and concentration influence mouse RBC lifespan.
- Mouse RBC transfusion is not a reliable model for human RBC longevity; however, modified human RBCs transfused into mice can serve as a model. Transfusion studies in large heterogeneous mammals require further investigation.
